Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released Nov 6, 2023, after the close
10-Q filed Nov 6, 2023, 37 days after period end · 0000950170-23-059415
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Net Income | -$25.48M | -$24.83M | -$18.43M | -$25.55M |
| EPS Diluted | -$0.44 | -$0.63 | -$0.47 | -$0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR